62 related articles for article (PubMed ID: 11045429)
1. Transduction and oncolytic profile of a potent replication-competent adenovirus 11p vector (RCAd11pGFP) in colon carcinoma cells.
Silver J; Mei YF
PLoS One; 2011 Mar; 6(3):e17532. PubMed ID: 21455297
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 12 secretion enhances antitumor efficacy of oncolytic herpes simplex viral therapy for colorectal cancer.
Bennett JJ; Malhotra S; Wong RJ; Delman K; Zager J; St-Louis M; Johnson P; Fong Y
Ann Surg; 2001 Jun; 233(6):819-26. PubMed ID: 11371740
[TBL] [Abstract][Full Text] [Related]
3. Clostridial spores as live 'Trojan horse' vectors for cancer gene therapy: comparison with viral delivery systems.
Wei MQ; Ren R; Good D; Anné J
Genet Vaccines Ther; 2008 Feb; 6():8. PubMed ID: 18279524
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic Adenovirus CD55-Smad4 Suppresses Cell Proliferation, Metastasis, and Tumor Stemness in Colorectal Cancer by Regulating Wnt/β-Catenin Signaling Pathway.
Xiao B; Zhang L; Liu H; Fang H; Wang C; Huang B; Liu X; Zhou X; Wang Y
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33322272
[TBL] [Abstract][Full Text] [Related]
5. Synergistic antitumor effect of adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase and nucleoside analogs for human breast carcinoma in vitro and in vivo.
Tang M; Zu C; He A; Wang W; Chen B; Zheng X
Drug Des Devel Ther; 2015; 9():3301-12. PubMed ID: 26203222
[TBL] [Abstract][Full Text] [Related]
6. A rationally designed A34R mutant oncolytic poxvirus: improved efficacy in peritoneal carcinomatosis.
Thirunavukarasu P; Sathaiah M; Gorry MC; O'Malley ME; Ravindranathan R; Austin F; Thorne SH; Guo ZS; Bartlett DL
Mol Ther; 2013 May; 21(5):1024-33. PubMed ID: 23439499
[TBL] [Abstract][Full Text] [Related]
7. Preclinical antitumor activity of a nanoparticulate SN38.
Al-Kasspooles MF; Williamson SK; Henry D; Howell J; Niu F; Decedue CJ; Roby KF
Invest New Drugs; 2013 Aug; 31(4):871-80. PubMed ID: 23299391
[TBL] [Abstract][Full Text] [Related]
8. Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models.
Zheng FQ; Xu Y; Yang RJ; Wu B; Tan XH; Qin YD; Zhang QW
Acta Pharmacol Sin; 2009 May; 30(5):617-27. PubMed ID: 19363518
[TBL] [Abstract][Full Text] [Related]
9. Armed replicating adenoviruses for cancer virotherapy.
Cody JJ; Douglas JT
Cancer Gene Ther; 2009 Jun; 16(6):473-88. PubMed ID: 19197323
[TBL] [Abstract][Full Text] [Related]
10. Targeted cancer gene therapy using a hypoxia inducible factor dependent oncolytic adenovirus armed with interleukin-4.
Post DE; Sandberg EM; Kyle MM; Devi NS; Brat DJ; Xu Z; Tighiouart M; Van Meir EG
Cancer Res; 2007 Jul; 67(14):6872-81. PubMed ID: 17638898
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolytic adenoviruses.
Vecil GG; Lang FF
J Neurooncol; 2003 Dec; 65(3):237-46. PubMed ID: 14682374
[TBL] [Abstract][Full Text] [Related]
12. Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus-thymidine kinase.
Wildner O; Blaese RM; Morris JC
Cancer Res; 1999 Jan; 59(2):410-3. PubMed ID: 9927055
[TBL] [Abstract][Full Text] [Related]
13. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
14. Replicative adenoviruses for cancer therapy.
Alemany R; Balagué C; Curiel DT
Nat Biotechnol; 2000 Jul; 18(7):723-7. PubMed ID: 10888838
[TBL] [Abstract][Full Text] [Related]
15. In situ use of suicide genes for therapy of brain tumours.
Wildner O
Ann Med; 1999 Dec; 31(6):421-9. PubMed ID: 10680856
[TBL] [Abstract][Full Text] [Related]
16. Therapy of peritoneal carcinomatosis from colon cancer with oncolytic adenoviruses.
Wildner O; Morris JC
J Gene Med; 2000; 2(5):353-60. PubMed ID: 11045429
[TBL] [Abstract][Full Text] [Related]
17. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
Wildner O; Morris JC
Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
